ALLR Stock Analysis: Buy, Sell, or Hold?
ALLR - Allarity Therapeutics, Inc. Common Stock
$0.82
-0.06 (-7.29%)
▼
5d:
-24.61%
30d:
-26.63%
90d:
-40.45%
WAIT
LOW Confidence
Analysis Updated: Feb 3, 2026 12:00 AM ET
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ALLR this week
0% bullish • 2 bearish
0% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALLR is down 24.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALLR is down 24.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $1.01 to $1.22.
Technical Outlook: Technically, ALLR is in a strong downtrend. Immediate support is located at $0.77, while resistance sits at $1.26. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.25 (+943.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALLR is in a strong downtrend. Immediate support is located at $0.77, while resistance sits at $1.26. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.25 (+943.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.01 -
$1.22
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 943.5% below Wall St target ($9.25)
- WARNING: Recommendation downgraded due to -24.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.01 -
$1.22
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.77
Resistance Level
$1.27
Current Trend
Strong Downtrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.97
Wall Street Target
$9.25
(+943.5%)
Last updated: February 04, 2026 11:06 AM ET
Data refreshes hourly during market hours. Next update: 12:06 PM
Data refreshes hourly during market hours. Next update: 12:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
